Axitinib For The Treatment Of Advanced Hepatocellular Carcinoma

Clinical trial NCT01210495 · COMPLETED

Trial details

NCT number: NCT01210495
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2010-12-06
Primary completion: 2014-03-03
Enrollment: 224

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.